Next-Generation Sequencing and Advanced Therapies – A New Safety Net
Posted on October 20, 2021
Colette Côté, Ph.D., Chief Portfolio Officer and US General Manager, PathoQuest
Introduction Advanced therapy medicinal products (ATMPs) which comprise cell and gene therapies, as well as tissue-engineered medicinal products, have brought about extraordinary gains for patient care. To dig deeper into their biosafety, as there are as many viral safety strategies as there are ATM...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
